Group 1 - The core viewpoint of the news is that He Yuan Bio experienced a slight increase in stock price and notable changes in financing activities on January 27, with a net financing outflow [1] - On January 27, He Yuan Bio's stock rose by 0.85%, with a trading volume of 217 million yuan, and a financing buy-in amount of 16.12 million yuan, while the financing repayment was 25.13 million yuan, resulting in a net financing outflow of 9.01 million yuan [1] - As of January 27, the total balance of margin trading for He Yuan Bio was 262 million yuan, which represents 7.72% of its circulating market value [1] Group 2 - As of October 28, the number of shareholders for He Yuan Bio reached 47,100, marking an increase of 84,075% compared to the previous period, while the average circulating shares per person decreased by 99.85% to 869 shares [2] - For the period from January to September 2025, He Yuan Bio reported an operating income of 19.66 million yuan, reflecting a year-on-year decrease of 8.51%, and a net profit attributable to the parent company of -121 million yuan, also a decrease of 8.44% year-on-year [2]
禾元生物1月27日获融资买入1611.76万元，融资余额2.62亿元